Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Other solid neoplasm 2Gynecologic 2Breast 2Thoracic 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Iohexol × Gastrointestinal × Clear all
NCT04582500 2025-04-04

Virtual Colonoscopy Using Omnipaque as a Contrast Agent

Montefiore Medical Center

Completed
50 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01326364 2016-07-01

Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

Stanford University

Terminated
6 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00576563 2016-04-21

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Maastricht Radiation Oncology

Phase NA Completed
103 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01200303 2015-08-05

ncCTC

Massachusetts General Hospital

Phase 2/3 Completed
605 enrolled
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡